ClearPoint Neuro (CLPT) Operating Expenses (2011 - 2026)

ClearPoint Neuro has disclosed Operating Expenses across 15 years of filings, most recently posting $9.5 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $9.5 million, up 27.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $32.5 million (up 22.98% YoY), and the FY2025 annual result was $30.4 million, up 24.68% from the prior year.
• Operating Expenses came in at $9.5 million for Q1 2026 at ClearPoint Neuro, up from $8.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $9.5 million in Q1 2026 to a low of $5.1 million in Q3 2022.
• The 5-year median for Operating Expenses is $6.0 million (2023), against an average of $6.4 million.
• Across the five-year window, Operating Expenses surged 57.67% in 2022 and slipped 13.34% in 2024, its largest moves.
• ClearPoint Neuro's Operating Expenses stood at $5.3 million in 2022, then gained by 1.3% to $5.4 million in 2023, then gained by 22.73% to $6.6 million in 2024, then jumped by 31.64% to $8.7 million in 2025, then rose by 9.68% to $9.5 million in 2026.
• The last three Operating Expenses figures came in at $9.5 million (Q1 2026), $8.7 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.